title: [Supportive care in multiple myeloma for continuing anti-myeloma therapies].
authors.forename: Hirohiko
authors.initials: H
authors.lastname: Shibayama
mesh_terms: D000740:Anemia / Q000209:etiology; D050071:Bone Density Conservation Agents / Q000627:therapeutic use; D001851:Bone Diseases, Metabolic / Q000188:drug therapy / Q000209:etiology; D001897:Boronic Acids / Q000009:adverse effects / Q000627:therapeutic use*; D000069286:Bortezomib; D004164:Diphosphonates / Q000627:therapeutic use; D006801:Humans; D006934:Hypercalcemia / Q000209:etiology; D007674:Kidney Diseases / Q000188:drug therapy / Q000209:etiology; D000077269:Lenalidomide; D009101:Multiple Myeloma / Q000150:complications* / Q000188:drug therapy*; D010523:Peripheral Nervous System Diseases / Q000188:drug therapy / Q000209:etiology; D011719:Pyrazines / Q000009:adverse effects / Q000627:therapeutic use*; D013792:Thalidomide / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000627:therapeutic use*
chemical_list: D050071:Bone Density Conservation Agents; D001897:Boronic Acids; D004164:Diphosphonates; D011719:Pyrazines; D013792:Thalidomide; D000069286:Bortezomib; D000077269:Lenalidomide